Overview of CAR T cells granted with marketing authorizations (MA) in the European Union by January 2023, including extensions of their MA. BCMA, B-cell maturation antigen; FL, follicular lymphoma; HGBCL, high-grade B-cell lymphoma; MCL, mantle cell lymphoma; MM, multiple myeloma; PMBCL, primary mediastinal B-cell lymphoma.